Stockscreener 앱 받기
3.17%
전일 마감가:
$693.53
열려 있는:
$698.85
하루 거래량:
1.11M
Relative Volume:
1.45
시가총액:
$89.21B
수익:
$344.58B
순이익/손실:
$2.83B
주가수익비율:
32.71
EPS:
21.84
순현금흐름:
$1.63B
1주 성능:
+7.49%
1개월 성능:
+11.02%
6개월 성능:
+48.37%
1년 성능:
+32.48%
1일 변동 폭
$696.50
$724.00
1주일 범위
$659.48
$724.00
52주 변동 폭
$464.42
$724.00
맥케슨 Stock (MCK) Company Profile
명칭
Mckesson Corporation
전화
972-446-4800
주소
6555 STATE HIGHWAY 161, IRVING, TX
MCK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
714.72 | 89.21B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
286.57 | 55.56B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
135.88 | 33.78B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
67.19 | 8.23B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.27 | 2.75B | 6.55B | 155.22M | -823.13M | 1.71 |
맥케슨 Stock (MCK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-04 | 재개 | Mizuho | Neutral |
| 2024-11-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-09-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-09-05 | 재확인 | Leerink Partners | Outperform |
| 2024-08-08 | 재확인 | Mizuho | Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Overweight |
| 2022-07-06 | 다운그레이드 | Argus | Buy → Hold |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-01-07 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-11-02 | 재확인 | Barclays | Overweight |
| 2021-11-02 | 재확인 | BofA Securities | Buy |
| 2021-11-02 | 재확인 | Evercore ISI | Outperform |
| 2021-11-02 | 재확인 | Jefferies | Buy |
| 2021-03-30 | 업그레이드 | Argus | Hold → Buy |
| 2020-11-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-08-04 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-05-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-05-15 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-03-18 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-05 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2019-07-22 | 개시 | Guggenheim | Neutral |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2018-10-26 | 재확인 | Barclays | Equal Weight |
| 2018-07-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2018-05-29 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-03-08 | 개시 | Barclays | Equal Weight |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-02 | 재확인 | Mizuho | Neutral |
| 2018-01-24 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
맥케슨 주식(MCK)의 최신 뉴스
Deutsche Bank Adjusts Price Target on McKesson to $692 From $700, Maintains Buy Rating - MarketScreener
McKesson price target raised to $690 from $630 at Mizuho - TipRanks
Mizuho raises McKesson stock target to $690, maintains neutral - Investing.com India
McKesson Shares Up Over 2% After Key Signal - Benzinga
McKesson Gets Drugs to Patients. Buy the Stock for Healthy Returns. - Barron's
McKesson (MCK) Poised for Growth in Pharmaceutical Distribution - GuruFocus
Whistleblower Asks Justices to Revive Suit Against McKesson Unit - Bloomberg Law News
McKesson: Morgan Stanley's Top Choice For Pharmaceutical Gains - Finimize
McKesson Likely to See Strong Growth Amid Favorable Pharma Sector, Morgan Stanley Says - MarketScreener
McKesson completes $850M majority stake purchase in eye care company - The Business Journals
McKesson acquires Prism Vision Holdings - Drug Store News
McKesson Corporation Completes Acquisition of PRISM Vision Holdings - citybiz
McKesson Closes $850 Million Acquisition of Controlling Stake in Prism Vision - MarketScreener
Healthcare Giant McKesson Takes Control of PRISM Vision for $850M, Eyes Ophthalmology Leadership - Stock Titan
Morgan Stanley Raises Price Target on McKesson to $745 From $642, Keeps Overweight Rating - MarketScreener
Morgan Stanley lifts McKesson stock target to $745, keeps Overweight rating - Investing.com
Radiology Information System Market Forecast Report and Company Analysis 2025-2033 Featuring Koninklijke Philips, Siemens Healthcare, Oracle, McKesson, GE, Fujifilm, Shimadzu, Hologic, Sectra - GlobeNewswire Inc.
McKesson Corporation completed the acquisition of 80% stake in PRISM Vision Group from Quad-C Management, Inc. - MarketScreener
What's Driving the Market Sentiment Around McKesson? - Benzinga
McKesson (MCK) Laps the Stock Market: Here's Why - Yahoo Finance
Investing in McKesson (NYSE:MCK) five years ago would have delivered you a 451% gain - Yahoo Finance
McKesson Careers | The future of health starts with you. - McKesson Careers
Is McKesson Corporation (MCK) the Best S&P 500 Stock to Buy for Dividend Growth? - Insider Monkey
McKesson stock soars to all-time high, hits $672 - Investing.com
McKesson stock soars to all-time high, hits $672 By Investing.com - Investing.com South Africa
Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy? - Yahoo Finance
Q4 Earnings Outperformers: McKesson (NYSE:MCK) And The Rest Of The Healthcare Providers & Services Stocks - Yahoo Finance
Deutsche Bank Raises Price Target on McKesson to $700 From $663 - MarketScreener
McKesson (MCK): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock - Yahoo Finance
With 89% institutional ownership, McKesson Corporation (NYSE:MCK) is a favorite amongst the big guns - Yahoo Finance
McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025 (NYSE:MCK) - Seeking Alpha
McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note - MSN
Trade Tracker: Joe Terranova buys Interactive Brokers and McKesson, sells CVS - CNBC
Is McKesson Corporation (MCK) The Best Healthcare Dividend Stock to Invest in? - Insider Monkey
McKesson (MCK) and Visa (V) Are 2 Dividend Growth Stocks to Buy For a Lifetime of Passive Income - 24/7 Wall St.
McKesson stock soars to all-time high of $667.08 amid robust growth - Investing.com Australia
McKesson stock soars to all-time high of $667.08 amid robust growth By Investing.com - Investing.com South Africa
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
McKesson Stock Outshines Alphabet Amid Economic Volatility - Evrim Ağacı
Fortune 50 company puts local facility in midst of closing up for sale - The Business Journals
Telehealth Market Set to Witness Significant Growth by 2025-2032: McKesson Corporation, Cisco Systems, Inc, - EIN News
With 89% ownership of the shares, McKesson Corporation (NYSE:MCK) is heavily dominated by institutional owners - Simply Wall St
American Express Chief Legal Officer earns $11 million compensation in 2024 - ETLegalworld
Wells Fargo Adjusts Price Target on McKesson to $691 From $641, Maintains Equalweight Rating - Marketscreener.com
McKesson Sees Its Composite Rating Rise To 96 - Investor's Business Daily
McKesson (MCK) Advances While Market Declines: Some Information for Investors - Yahoo Finance
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
맥케슨 (MCK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.75%
1.67%
자본화:
|
볼륨(24시간):